Patent classifications
B01D61/149
METHOD FOR SEPARATION OF POTATO PROTEINS AND INSOLUBLE FIBERS FROM PHENOLIC AND/OR GLYCOALKALOID COMPOUNDS
The present invention concerns a method for separation of (a) potato proteins and insoluble fibers from (b) first salts and phenolic and/or glycoalkaloid compounds in potato fruit juice or a derivative thereof, said method comprising the steps of: (i) providing a potato fruit juice or a derivative thereof, comprising potato proteins; and insoluble fibers; and one or more first salts; and phenolic and/or glycoalkaloid compounds; (ii) subjecting the potato fruit juice or the derivative thereof to a first cross-flow membrane filtration process resulting in a first retentate and a first permeate; and (iii) adding aqueous diafiltration liquid containing one or more salts to the first retentate and performing a second cross-flow membrane filtration as diafiltration, to create a second permeate containing at least a portion of said phenolic and/or glycoalkaloid compounds and salts and a second retentate comprising potato proteins, salts and insoluble fibers.
The present invention further concerns a potato fruit juice product comprising potato protein and insoluble fibers, such as a potato fruit juice product obtainable by the method according to the invention.
PROTEIN COMPOSITIONS PRODUCED FROM HEMP PLANT MATERIALS
Disclosed are plant protein compositions prepared from hemp plant material. Hemp seeds are deconstructed and separated into heavy protein-rich fractions and light oil-rich fractions. The deconstruction processes avoid the use of organic solvents and temperatures above 60° C. The separated fractions are then selectively processed to produce selected plant protein containing compositions comprising from about 30% (w/w) to about 95% hemp protein, from about 5% (w/w) and to about 60% (w/w) plant oil. The plant protein compositions from hemp plants are suitable for use as ingredients in nutritional formulations.
METHOD AND SYSTEM OF REMOVING ENVIRONMENTAL CONTAMINANTS FROM WATER
A method and system of removing environmental contaminants from water comprising adding a fatty chemical to form a mixture with the water in which the fatty chemical and the environmental contaminants complex to form molecular complexes. The mixture is then filtered to remove the molecular complexes from the water.
PROCESS FOR ISOLATING SOLUBLE FUNCTIONAL PROTEINS FROM PLANT MATERIAL
A process for obtaining soluble functional proteins from plant material includes the steps of: mechanically disrupting the cells of the plant material to obtain a mush stream; subjecting the mush stream to a coarse physical separation step, resulting in a permeate and a retentate; subjecting the permeate P.sub.b to mild treatment, resulting in a treated permeate; subjecting the treated permeate to serial centrifugation steps; subjecting centrate to a microfiltration step resulting in a permeate and a retentate; subjecting the permeate to an ultrafiltration step resulting in a permeate and a retentate; subjecting the retentate to hydrophobic column adsorption to provide a column permeate and a retentate; and drying the column permeate to provide a soluble functional protein isolate.
BIOPROCESSING PERFUSION SYSTEM HAVING A PLURALITY OF FILTERS AND METHOD OF OPERATING THE SAME
The bioprocessing perfusion system (10) includes a bioreactor (12) and a feed flow path (14). A first tangential flow filter (16) is coupled to the bioreactor (12) via the feed flow path (14) and a second tangential flow filter (18) is coupled to the bioreactor (12) via the feed flow path (14). The first tangential flow filter (16) is a microfiltration-type filter and the second tangential flow filter (18) is an ultrafiltration-type filter. The first tangential flow filter (16) and the second tangential flow filter (18) are further coupled to a receiving unit (58) via the permeate flow path (60). The first tangential flow filter (16) and the second tangential flow filter (18) are further coupled to the bioreactor (12) via the retentate flow path (46). A control unit (82) is communicatively coupled to the first feed control device (42), the second feed control device (44), the feed drive unit (40), the first permeate control device (64), the second permeate control device (66), the first retentate control device (48), and the second retentate control device (50).
Tangential flow filter system for the filtration of materials from biologic fluids
Systems and methods for filtering materials from biologic fluids are discussed. Embodiments may be used to filter cerebrospinal fluid (CSF) from a human or animal subject. In an example, CSF is separated into a permeate and retentate using a tangential flow filter. The retentate is filtered again and then returned to the subject with the permeate. During operation of the system, various parameters may be modified, such as flow rate and waste rate.
METHODS OF PREPARING VIRAL VECTORS
This disclosure relates generally to process filtration systems, and more particularly to systems utilizing tangential flow filtration.
TANGENTIAL FLOW FILTER SYSTEM FOR THE FILTRATION OF MATERIALS FROM BIOLOGIC FLUIDS
Systems and methods for filtering materials from biologic fluids are discussed. Embodiments may be used to filter cerebrospinal fluid (CSF) from a human or animal subject. In an example, CSF is separated into a permeate and retentate using a tangential flow filter. The retentate is filtered again and then returned to the subject with the permeate. During operation of the system, various parameters may be modified, such as flow rate and waste rate.
MESENCHYMAL STEM CELL COMPOSITIONS AND METHODS OF MAKING
Disclosures herein are directed to first compositions comprising exosomes and extracellular matrix components and their use thereof. Also described are methods and kits wherein these first compositions are packaged and used with second compositions comprising mesenchymal stem cells. The first and second compositions are derived from the same tissue source using tangential flow filtration.
MODULAR DRUG PRODUCTION SYSTEM
A portable system for producing a formulation comprising lipid nanoparticle (LNP)-encapsulated RNA includes: a first sub-system comprising multiple drug substance formulation modules, the first sub-system comprising: a transcription module for forming an RNA solution via in vitro transcription; and a second sub-system operatively downstream of the first sub-system comprising multiple drug product formation modules, the second sub-system comprising: an LNP formulation module for producing a first RNA-LNP preparation from the RNA solution, wherein each of the transcription module and the LNP formulation module is contained within a separate standard shipping container.